Global Ziprasidone Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ917834
Publisher: Date of Publish:
No. of Pages: 136 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Executive Summary According to GRD Survey data, the global Ziprasidone market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027. This report studies the Ziprasidone market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Ziprasidone in these regions, from 2016 to 2027, covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Italy, Spain and Russia, etc.) Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.) Market Snapshot, By Product Type Oral Capsule Injection Market Snapshot, By Application Hospital Drug Store Market Snapshot, By Region: North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australia Central & South America Brazil Argentina Colombia Middle East & Africa Iran South Africa Israel Turkey Saudi Arabia Main Market Players Analyzed in this report, including: Zydus Pharmaceuticals Wockhardt Sandoz Pfizer Mylan Pharmaceuticals Macleods Pharmaceuticals Lupin Pharmaceuticals Dr. Reddy's Laboratories Aurobindo Apotex The study objectives of this report are: To study and analyze the global Ziprasidone market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027. To understand industry structure of Ziprasidone market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To identify the key global Ziprasidone manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Ziprasidone market with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Ziprasidone submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Ziprasidone are as follows: History Year: 2016-2020 Base Year: 2020 Estimated Year: 2021 Forecast Year 2021 to 2027 This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Considered in the study: Raw material vendors Distributors/traders/wholesalers/suppliers Regulatory authorities, including government agencies and NGO Commercial research & development (R&D) institutions Importers and exporters Government organizations, research organizations, and consulting firms Trade/Industrial associations End-use industries
Table of Contents 1 Market Definition & Scope 1.1 Definition & Scope 1.2 Ziprasidone Product Specifications 1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity) 1.4 Global Ziprasidone Market Performance and Outlook 2 Market Development Performance under COVID-19 2.1 Influencing Factors of Industry Development in the Next Five Years 2.1.1 Drivers 2.1.2 Restraints 2.1.3 Opportunities 2.2 Porter’s Five Forces Analysis 2.3 Comparison of Alternatives and Ziprasidone 3 Supply Chain and Manufacturing Cost Analysis 3.1 Supply Chain Analysis 3.2 Raw Materials and Key Suppliers Analysis 3.2.1 Raw Materials Introduction 3.2.1 Raw Materials Key Suppliers List 3.3 Ziprasidone Sales Channel and Distributors Analysis 3.3.1 Ziprasidone Sales Channel 3.3.2 Ziprasidone Distributors 3.4 Key Buying Industries/Consumers 3.4.1 Major Buyers in Hospital 3.4.2 Major Buyers in Drug Store 3.5 Ziprasidone Manufacturing Cost Structure Analysis 4 Market Segment: by Type 4.1 Ziprasidone Type Introduction 4.1.1 Oral Capsule 4.1.2 Injection 4.2 Global Ziprasidone Sales by Type 2016-2021 4.3 Global Ziprasidone Revenue by Type 2016-2021 4.4 Global Ziprasidone Price by Type 2016-2021 5 Market Segment: by Application 5.1 Ziprasidone Type Introduction 5.1.1 Hospital 5.1.2 Drug Store 5.2 Global Ziprasidone Sales by Application 2016-2021 5.3 Global Ziprasidone Revenue by Application 2016-2021 5.4 Global Ziprasidone Price by Application 2016-2021 6 Marke Segment: by Region 6.1 Global Ziprasidone Market by Region 6.1.1 Global Ziprasidone Sales by Regions 6.1.2 Global Ziprasidone Revenue by Regions 6.2 North America Ziprasidone Market 2016-2021 6.3 Europe Ziprasidone Market 2016-2021 6.4 Asia Pacific Ziprasidone Market 2016-2021 6.5 South America Ziprasidone Market 2016-2021 6.6 Middle East and Africa Ziprasidone Market 2016-2021 7 North America 7.1 North America Ziprasidone Market by Country 2016-2021 7.1.1 North America Ziprasidone Sales by Country 7.1.2 North America Ziprasidone Revenue by Country 7.2 United States 7.3 Canada 7.4 Mexico 8 Europe 8.1 Europe Ziprasidone Market by Country 2016-2021 8.1.1 Europe Ziprasidone Sales by Country 8.1.2 Europe Ziprasidone Revenue by Country 8.2 Germany 8.3 France 8.4 UK 8.5 Italy 8.6 Russia 8.7 Spain 9 Asia Pacific 9.1 Asia Pacific Ziprasidone Market by Country 2016-2021 9.1.1 Asia Pacific Ziprasidone Sales by Country 9.1.2 Asia Pacific Ziprasidone Revenue by Country 9.2 China 9.3 Japan 9.4 Korea 9.5 Southeast Asia 9.6 India 9.7 Australia 10 South America 10.1 South America Ziprasidone Market by Country 2016-2021 10.1.1 South America Ziprasidone Sales by Country 10.1.2 South America Ziprasidone Revenue by Country 10.2 Brazil 10.3 Argentina 10.4 Colombia 11 Middle East and Africa 11.1 Middle East and Africa Ziprasidone Market by Country 2016-2021 11.1.1 Middle East and Africa Ziprasidone Sales by Country 11.1.2 Middle East and Africa Ziprasidone Revenue by Country 11.2 Turkey 11.3 Saudi Arabia 11.4 South Africa 12 Key Participants Company Information 12.1 Zydus Pharmaceuticals 12.1.1 Zydus Pharmaceuticals Company Information 12.1.2 Zydus Pharmaceuticals Ziprasidone Product Portfolio, Specification and Application 12.1.3 Zydus Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.1.4 Zydus Pharmaceuticals Key Development 12.2 Wockhardt 12.2.1 Wockhardt Company Information 12.2.2 Wockhardt Ziprasidone Product Portfolio, Specification and Application 12.2.3 Wockhardt Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.2.4 Wockhardt Key Development 12.3 Sandoz 12.3.1 Sandoz Company Information 12.3.2 Sandoz Ziprasidone Product Portfolio, Specification and Application 12.3.3 Sandoz Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.3.4 Sandoz Key Development 12.4 Pfizer 12.4.1 Pfizer Company Information 12.4.2 Pfizer Ziprasidone Product Portfolio, Specification and Application 12.4.3 Pfizer Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.4.4 Pfizer Key Development 12.5 Mylan Pharmaceuticals 12.5.1 Mylan Pharmaceuticals Company Information 12.5.2 Mylan Pharmaceuticals Ziprasidone Product Portfolio, Specification and Application 12.5.3 Mylan Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.5.4 Mylan Pharmaceuticals Key Development 12.6 Macleods Pharmaceuticals 12.6.1 Macleods Pharmaceuticals Company Information 12.6.2 Macleods Pharmaceuticals Ziprasidone Product Portfolio, Specification and Application 12.6.3 Macleods Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.6.4 Macleods Pharmaceuticals Key Development 12.7 Lupin Pharmaceuticals 12.7.1 Lupin Pharmaceuticals Company Information 12.7.2 Lupin Pharmaceuticals Ziprasidone Product Portfolio, Specification and Application 12.7.3 Lupin Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.7.4 Macleods Pharmaceuticals Key Development 12.9 Aurobindo 12.9.1 Aurobindo Company Information 12.9.2 Aurobindo Ziprasidone Product Portfolio, Specification and Application 12.9.3 Aurobindo Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.9.4 Aurobindo Key Development 12.8 Dr. Reddy's Laboratories 12.8.1 Dr. Reddy's Laboratories Company Information 12.8.2 Dr. Reddy's Laboratories Ziprasidone Product Portfolio, Specification and Application 12.8.3 Dr. Reddy's Laboratories Ziprasidone Sales, Price, Revenue and Gross Margin (2019-2021) 12.8.4 Dr. Reddy's Laboratories Key Development 13 Global Ziprasidone Market Forecast by Region by Type and by Application 13.1 Global Ziprasidone Sales, Revenue Forecast 2022-2027 13.2 Global Ziprasidone Forecast by Regions 13.2.1 Global Ziprasidone Sales Forecast by Region 2022-2027 13.2.2 Global Ziprasidone Revenue Forecast by Region 2022-2027 13.3 Global Ziprasidone Forecast by Type 13.3.1 Global Ziprasidone Sales Forecast by Type 2022-2027 13.3.2 Global Ziprasidone Revenue Forecast by Type 2022-2027 13.3.3 Global Ziprasidone Price Forecast by Type 2022-2027 13.4 Global Ziprasidone Forecast by Application 13.4.1 Global Ziprasidone Sales Forecast by Application 2022-2027 13.4.2 Global Ziprasidone Revenue Forecast by Application 2022-2027 13.4.3 Global Ziprasidone Price Forecast by Application 2022-2027 14 Analyst Views and Conclusions 15 Methodology and Data Source 15.1 Methodology 15.2 Research Data Source 15.2.1 Secondary Data 15.2.2 Primary Data 15.2.3 Market Size Estimation 15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com